|
骨髓干细胞的可塑性及其在栓塞性疾病中的应用 |
| |
云,等. 粒细胞集落刺激因子动员骨髓干细胞治疗大鼠缺血性脑梗死[J]. 中国病理生理杂志, 2004,20(4):560565.
[13] YAO XL, ZHANG C, LU XL, et al. Experimental research on effect of human mesenchymal stem cells induced by shenqi fuzheng injection in cerebral infarction[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2005, 25(7):623632.
[14] BANG OY, LEE JS, LEE PH, et al. Autologous mesenchymal stem cell transplantation in stroke patients[J]. Ann Neurol, 2005, 57(6):874882.
[15] KUROZUMI K, NAKAMURA K, TAMIYA T, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model[J]. Mol Ther, 2005, 11(1):96104.
[16] ESATO K, HAMANO K, LI TS, et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease[J]. Cell Transplant, 2002, 11(8):747752.
[17] HASEBE H, OSADA M, KODAMA Y, et al. Therapeutic angiogenesis by autologoustransplantation of bonemarrow cells in a patient with progressive limb ischemia due to arteriosclerosis obliterans: a case report[J]. Cardiol, 2004, 43(4):179183.
[18] BARTSCH T, BREHM M, FALKE T, et al. Rapid healing of a therapyrefractory diabetic 上一页 [1] [2] [3] [4] [5] [6] 下一页
上一个医学论文： HIF 1 VEGF与缺血性脑血管病
下一个医学论文： 影响华法林抗凝作用的因素
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文